⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 6, 2026npj Parkinson s DiseaseOpen Access

Matters arising: critical appraisal of device aided therapy outcomes in Parkinson’s disease

Qingliu Zheng Changyun Liu

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to critically appraise the real-world outcomes of device-aided therapies for individuals with Parkinson's disease.
Evaluated methodological approaches used in past studies on device-aided therapies.
Provided clinical perspectives regarding the effectiveness and implementation of these therapies.
Identified gaps and variations in outcomes associated with device-aided therapies.
Highlighted the need for standardized methodologies to better assess therapy effectiveness.

Implication

Comment reviews the effectiveness of device-aided therapies in Parkinson's disease, suggesting insights for clinical practice.

Abstract

This Comment provides methodological insights and clinical perspectives on real-world outcomes of device-aided therapies in Parkinson’s disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zheng et al. (2026) studied this question.

synapsesocial.com/papers/69fd8021bfa21ec5bbf0881c https://doi.org/10.1038/s41531-026-01342-7

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertaintyreview · 2023 · 49 citations
2Device aided therapies in Parkinson disease: an expert view on apomorphineReview · 2026
3Parkinson's disease quality of life at 12 months comparing invasive device-aided therapy with oral treatment.2025
4Impact of Device-aided Therapies on Quality of Life in Patients with Parkinson´s Disease. A Comparative Multicenter Observational Study.2025 · 1 citations
5Levodopa-based device-aided therapies for the treatment of advanced Parkinson’s disease: a social return on investment analysis2024 · 1 citations